Clinical Trials Directory

Trials / Unknown

UnknownNCT05792696

PPI Guided Strategies for Prevention and Treatment of Intraoperative Hypotension

Effectiveness of Peripheral Perfusion Index Guided Strategies for the Prevention and Treatment of Hypotension: a Randomized Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
zhiqiang zhou · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Intraoperative hypotension is closely related to the poor prognosis of surgery. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia.

Detailed description

Intraoperative hypotension is closely related to the poor prognosis of surgery. Hypotension decreased blood flow perfusion of organs, which lead to dysfunction of multiple organs, especially increasing serious complications such as cardio-cerebrovascular events and acute renal injury within 30 days after surgery. The aim of this study is to establish a set of strategies that can effectively prevent and treat intraoperative hypotension, so as to alleviate possible harm to patients from perioperative hypotension. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia. The lower target mean arterial pressure (MAP) was higher than 65 mmHg. MAP less than 65 mmHg was defined as intraoperative hypotension between induction and tracheal extubation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPPI guided strategiesFor targeted MAP or lower, if PPI\<1, more fluid therapy. if PPI\>3, vasoconstriction therapy. For MAP\<65mmHg and 1\<=PPI\<3, test bolus of 250 ml crystalloid fluid.
BEHAVIORALEmpirical strategiesFluid therapy or vasoconstriction depended on experiences of anesthetic staffs.

Timeline

Start date
2024-01-01
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2023-03-31
Last updated
2024-10-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05792696. Inclusion in this directory is not an endorsement.